Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products. From beginnings in the production of synthetic fabric dyes, the companies that eventually became Novartis branched out into producing chemicals and ultimately pharmaceuticals.

The history of Novartis traces the converging destinies of three companies: Geigy, a chemicals and dyes trading company founded in Basel, Switzerland in the middle of the 18th century; Ciba, which began producing dyes in 1859; and Sandoz, a chemical company founded in Basel in 1886.

These companies shared a common trait which lives on at Novartis: a passion for developing and marketing new products that contribute to human progress through advances in science and health. Building on this heritage, today Novartis focuses its innovation prowess on addressing the unmet needs of patients worldwide.

For more information, please visit

About Novartis in Egypt

Novartis has been present in Egypt for more than 58 years. We have a legacy of commitment to patients, to Egyptian society, to the local healthcare industry and to the national economy. Our ongoing investments in research and development, in manufacturing, in infrastructure and in patient support programs seek to improve and extend people’s lives. Novartis has been the leading pharmaceutical company in Egyptian pharma market, we see it as our calling to reimagine medicine and to use innovative science and digital technologies to create transformative treatments in areas of great medical need.